Dr. David Minas Hovsepian, MD

Dr. Hovsepian practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University.

Dr. Hovsepian's NPI, 1619995255, was assigned on July 18, 2006. Dr. Hovsepian graduated from Vagelos College of Physicians and Surgeons in 1986. Dr. Hovsepian holds California license G88032.

Dr. Hovsepian's primary practice is Lucile Packard Children's Hospital Stanford, at 725 Welch Road, Palo Alto, CA 94304 in Santa Clara County. The practice phone is (650) 497-8000.

Dr. Hovsepian's primary practice is Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University. Dr. Hovsepian is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Hovsepian to 1 more medical group, named with a free account. Dr. Hovsepian's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hovsepian practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Hovsepian's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Hovsepian is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Hovsepian's licenses on file in 4 states: California, Colorado, Pennsylvania and New York.

CMS data shows 23 Medicare services from Dr. Hovsepian across 1 procedure code in 2024, for 49 Medicare patients. Medicare paid $240 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 49 Medicare patients who saw Dr. Hovsepian in 2024. The largest group is under 65, with 16 patients. 73% of them have high blood pressure, and 49% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hovsepian's median patient age at 14, with 51% women.

In 2024, Dr. Hovsepian wrote 27 Medicare Part D claims for 13 patients. 96% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Hovsepian for performance year 2024, reported as part of a group. Dr. Hovsepian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 85 papers to Dr. Hovsepian, published from 2002 to 2024. 2011 was the busiest year, with 6. The most frequent topics are Embolization, Therapeutic, Leiomyoma and Uterine Neoplasms. Dr. Hovsepian has published most often in J Vasc Interv Radiol. Dr. Hovsepian's most frequent co-authors are William Tom Kuo, MD, John Louie, MD and Daniel D. Picus, MD.

Dmand AI links Dr. Hovsepian to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Postphlebitic Syndrome, Postthrombotic Syndrome and Pulmonary Embolism. Stanford University sponsors the most, 3.

CMS Open Payments shows 44 general payments to Dr. Hovsepian from 19 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 63% of the total. Siemens Medical Solutions USA, Inc. paid the most, $7,377.

Dmand AI lists 2 awards for Dr. Hovsepian, most recently America's Top Doctors in 2018.

Dr. Hovsepian graduated from Vagelos College of Physicians and Surgeons in 1986. Dr. Hovsepian is a member of SIR.

Dr. Hovsepian is in network with 3 carriers, including AR State Medicaid, CMS Medicare and NV State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.